GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-188774 | Pharmaceuticals and Medical
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Gastrointestinal Infection Diagnostic Testing Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET
7.1 GLOBAL GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA GASTROINTESTINAL INFECTION DIAGNOSTIC TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Quidel Corporation
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Hoffmann-La Roche Ltd
16.3 Thermo Fisher Scientific Inc
16.4 Luminex Corporation
16.5 Seegene Inc
16.6 Illumina, Inc
16.7 Bio-Rad Laboratories Inc
16.8 bioMérieux SA
16.9 Genetic Signatures
16.10 Becton, Dickinson and Company (BD)
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredImaging Tests
Biopsy
Laboratory Tests
Major Downstream Industry Covered
Academic Institutes
Ambulatory Surgical Centers
Hospitals
Research Organizations
Diagnostic Imaging Centers and Laboratories
Companies
Quidel Corporation
Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc
Luminex Corporation
Seegene Inc
Illumina, Inc
Bio-Rad Laboratories Inc
bioMérieux SA
Genetic Signatures
Becton, Dickinson and Company (BD)
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.